Overview

DIA brings you a symposium with interactive dynamics, where you will engage in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America. Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape.
Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.

We will be translating:

English to Spanish and Portuguese
Spanish to English and Portuguese
Portuguese to English and Spanish

LETTER TO SUPPORT YOUR US VISA APPLICATION
DIA can provide a letter to confirm your onsite participation as long as you have:

Already registered for this conference and
Paid the registration for this conference

To request a confirmation letter please send an email to Megan Stevens at Megan.Stevens@diaglobal.org.

On-Demand Content Preview Webinar

The US FDA Generic Drug Program – The Framework to "Sameness"
Gain an overview of the legal framework for how generic drugs can be developed for approval in the United States, and more.
Register today.

New Podcast!

Promoting Patient-Centric Business: MedComm in Latin America
Hear Barbara Nardi, Associate Director of Medical Communications, PPD, Brazil, and Emanuela Lopes Fernandes Saraiva, Customer Service and Medical Information Manager in Pharmacovigilance, Libbs Farmaceutica, Brazil, discuss topics from DIA's Latin America Medical Information and Communication Workshop.
Listen in.

Featured

Want to learn more about Latin America Regulatory Conference? You've come to the right site!

Who should attend?

Professionals involved in:

Learning objectives

At the conclusion of this conference, participants should be able to:

Discuss various initiatives related to global regulatory convergence and harmonization and their impact on the access of medicines and future R&D in Latin America
Examine various approaches and best practices to ensure regulatory reliance in Latin America

Program Committee

Mario Alanis, PhD Senior Advisor
Erudee Foundation, Frpath, Mexico
Peter Baker International Relations Specialist, OIP, OGROP
FDA, United States
Maria Guazzaroni Jacobs, PhD Director, Quality Intelligence, Global Supply
Pfizer Inc, United States
Maria Cristina Mota Pina, MBA Head, Regulatory Policy for Emerging Markets -Japan and Australia
AbbVie, United States
Jaime Oliveira, DrPH, AHIP Head Regulatory Policy and Intelligence LatAm
Bayer S.A., Brazil
Patricia Oliveira Pereira Tagliari, LLM, MPH Associate Director of the Second Directorate
ANVISA, Brazil
Ana Padua, MSc, RPh Director EU Global Regulatory and Scientific Policy
Merck Kgaa, Darmstadt, Germany (EMD Serono, US), Switzerland
Ana Pineda Zavaleta, MSc International Regulatory Analyst, LAO, OGPS, OPLIA, OC
FDA, United States
Analia Porras Unit Chief, Medicines and Health Technologies
Pan American Health Organization (PAHO), United States